Pharmacology in drug discovery : understanding drug response / Terry P. Kenakin.
Material type:
TextPublisher: Amsterdam : Academic Press, 2012Edition: first editionDescription: xi, 247 pages : illustrations, ports ; 24 cmContent type: - text
- unmediated
- volume
- 9780123848567 (pbk.)
- 0123848563 (pbk.)
- 615.1 K.T.P 23
- RM301.35 .K46 2012
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|
Books
|
Main library A10 | Pharmacy ( Pharmacology ) | 615.1 K.T.P (Browse shelf(Opens below)) | 1 | Available | 00009770 |
Browsing Main library shelves, Shelving location: A10 Close shelf browser (Hides shelf browser)
| No cover image available | ||||||||
| 615.1 K.B.B Basic & clinical pharmacology / | 615.1 K.B.B Basic & clinical pharmacology / | 615.1 K.B.B Basic & clinical pharmacology / | 615.1 K.T.P Pharmacology in drug discovery : understanding drug response / | 615.1 L Lippincott's illistrated reviews Pharmacology / | 615.1 L Pharmacology. | 615.1 L Lippincott's illistrated reviews Pharmacology / |
Includes bibliographical references and index.
Front Cover -- Pharmacology in Drug Discovery -- Copyright Page -- Contents -- Foreword -- Acknowledgements -- 1. Pharmacology: The Chemical Control of Physiology -- Pharmacology and Cellular Drug Response -- New Terminology -- Pharmacological Targets -- Dose-Response Curves -- Linking Observed Pharmacology With Molecular Mechanism -- Descriptive Pharmacology: I -- Summary -- References -- 2. Drug Affinity and Efficacy -- Introduction -- New Terminology -- Agonist Selectivity -- Affinity -- Efficacy -- Drugs with Multiple Efficacies -- Quantifying Agonist Activity -- Descriptive Pharmacology: II -- Summary -- Reference. 3. Predicting Agonist EffectAgonist Response in Different Tissues -- New Terminology -- The Black-Leff Operational Model of Agonism -- Applying the Black-Leff Model to Predict Agonism -- Descriptive Pharmacology: III -- Summary -- References -- 4. Drug Antagonism: Orthosteric Drug Effects -- Bi-Molecular Systems -- New Terminology -- What is Drug Antagonism? -- Antagonist Potency -- Mechanism(S) of Receptor Antagonism -- Orthosteric (Competitive and Non-Competitive) Antagonism -- Slow Dissociation Kinetics and Non-Competitive Antagonism -- Partial and Inverse Agonists -- Antagonist Effects in Vivo. Descriptive Pharmacology: IV Summary -- References -- 5. Allosteric Drug Effects -- Introduction -- New Terminology -- Protein Allosterism -- Types of Allosteric Modulators -- Unique Effects of Allosteric Modulators -- Detecting Allosterism -- Quantifying Allosteric Effect -- Descriptive Pharmacology: V -- Summary -- References -- 6. Enzymes as Drug Targets -- Introduction -- New Terminology -- Enzyme Kinetics -- Enzymes as Drug Targets -- Reversible Enzyme Inhibition -- Irreversible Enzyme Inhibition -- Intracellular Effects of Enzyme-Active Drugs -- Summary -- References -- 7. Pharmacokinetics I: Permeation and Metabolism. The Importance of Drug Concentration New Terminology -- "Drug-Like" Properties of Molecules -- Drug Absorption -- Drug Metabolism -- Oral Bioavailability -- Summary -- References -- 8. Pharmacokinetics II: Distribution and Multiple Dosing -- Drugs in Motion: in vivo Pharmacokinetics -- New Terminology -- The Central Compartment and in vivo Clearance -- Renal Excretion -- Drug Distribution -- Pharmacokinetics in vivo -- Scaling Data to Predict Human Pharmacokinetic Behavior -- Summary -- References -- 9. In Vivo Pharmacology -- Whole Body Drug Response -- New Terminology -- The "Dose" in Dose-Response -- What Constitutes Drug Response? The Importance of Kinetics in vivo Summary -- References -- 10. Safety Pharmacology -- Introduction -- New Terminology -- Safety Versus Toxicity -- Safety Pharmacology -- Early Safety Tests -- Hepatic Toxicity -- Summary -- References -- Appendix A: Answers to Chapter Questions -- Appendix B: Derivations and Proofs -- Index.
There are no comments on this title.